209 related articles for article (PubMed ID: 16897955)
21. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii.
Jongert E; de Craeye S; Dewit J; Huygen K
Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of protective effect of recombinant dense granule antigens GRA2 and GRA6 formulated in monophosphoryl lipid A (MPL) adjuvant against Toxoplasma chronic infection in mice.
Golkar M; Shokrgozar MA; Rafati S; Musset K; Assmar M; Sadaie R; Cesbron-Delauw MF; Mercier C
Vaccine; 2007 May; 25(21):4301-11. PubMed ID: 17418457
[TBL] [Abstract][Full Text] [Related]
23. Vaccination protects B cell-deficient mice against an oral challenge with mildly virulent Toxoplasma gondii.
Johnson LL; Lanthier P; Hoffman J; Chen W
Vaccine; 2004 Sep; 22(29-30):4054-61. PubMed ID: 15364456
[TBL] [Abstract][Full Text] [Related]
24. Toxoplasma gondii: DNA vaccination with genes encoding antigens MIC2, M2AP, AMA1 and BAG1 and evaluation of their immunogenic potential.
Dautu G; Munyaka B; Carmen G; Zhang G; Omata Y; Xuenan X; Igarashi M
Exp Parasitol; 2007 Jul; 116(3):273-82. PubMed ID: 17379212
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the immune response elicited by multi-antigenic DNA vaccine expressing SAG1, ROP2 and GRA2 against Toxoplasma gondii.
Xue M; He S; Cui Y; Yao Y; Wang H
Parasitol Int; 2008 Dec; 57(4):424-9. PubMed ID: 18562245
[TBL] [Abstract][Full Text] [Related]
26. Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice.
Peng GH; Yuan ZG; Zhou DH; He XH; Liu MM; Yan C; Yin CC; He Y; Lin RQ; Zhu XQ
Vaccine; 2009 Nov; 27(47):6570-4. PubMed ID: 19720368
[TBL] [Abstract][Full Text] [Related]
27. Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures.
Kato M; Claveria FG; Maki Y; Tanaka T; Suzuki N; Nagasawa H
Pathobiology; 2005; 72(3):160-4. PubMed ID: 15860934
[TBL] [Abstract][Full Text] [Related]
28. Control of Toxoplasma gondii infection by athymic LEW-Whn rnu rats.
Sepulveda-Arias JC; Kempf MC; Wiehr S; Wedekind D; Hedrich HJ; Gross U; Herrmann T
Parasite Immunol; 2008; 30(6-7):323-33. PubMed ID: 18433419
[TBL] [Abstract][Full Text] [Related]
29. [Effect of rmu-IFN-gamma on the splenic T cell subsets and NK cells of pregnant mice infected with Toxoplasma gondii].
Luo FJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Apr; 24(2):125-8. PubMed ID: 16862911
[TBL] [Abstract][Full Text] [Related]
30. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
Bhaumik SK; Naskar K; De T
Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
[TBL] [Abstract][Full Text] [Related]
31. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii.
Sharma SD; Hofflin JM; Remington JS
J Immunol; 1985 Dec; 135(6):4160-3. PubMed ID: 3877764
[TBL] [Abstract][Full Text] [Related]
32. Protection in mice immunized with a heterologous prime-boost regime using DNA and recombinant pseudorabies expressing TgSAG1 against Toxoplasma gondii challenge.
Shang L; Liu Q; Liu W; Men J; Gao S; Jiang L; Wang Z; Zhai Y; Jin H; Lian H; Chen C; Xia Z; Yuan Z; Zhu XQ
Vaccine; 2009 May; 27(21):2741-5. PubMed ID: 19428887
[TBL] [Abstract][Full Text] [Related]
33. Immunoregulation by Toxoplasma gondii infection prevents allergic immune responses in mice.
Wagner A; Förster-Waldl E; Garner-Spitzer E; Schabussova I; Kundi M; Pollak A; Scheiner O; Joachim A; Wiedermann U
Int J Parasitol; 2009 Mar; 39(4):465-72. PubMed ID: 18938169
[TBL] [Abstract][Full Text] [Related]
34. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production.
Roberts CW; Cruickshank SM; Alexander J
Infect Immun; 1995 Jul; 63(7):2549-55. PubMed ID: 7790068
[TBL] [Abstract][Full Text] [Related]
35. Maternal-fetal transmission of Toxoplasma gondii in interferon-gamma deficient pregnant mice.
Shiono Y; Mun HS; He N; Nakazaki Y; Fang H; Furuya M; Aosai F; Yano A
Parasitol Int; 2007 Jun; 56(2):141-8. PubMed ID: 17307382
[TBL] [Abstract][Full Text] [Related]
36. Spleen and lymph node cell populations, in vitro cell proliferation and interferon-gamma production during the primary immune response to Toxoplasma gondii.
Jones TC; Alkan S; Erb P
Parasite Immunol; 1986 Nov; 8(6):619-29. PubMed ID: 3101032
[TBL] [Abstract][Full Text] [Related]
37. Serum and aqueous humour cytokine response and histopathological alterations during ocular Toxoplasma gondii infection in C57BL/6 mice.
Calabrese KS; Tedesco RC; Zaverucha do Valle T; Barbosa HS
Micron; 2008 Dec; 39(8):1335-41. PubMed ID: 18343675
[TBL] [Abstract][Full Text] [Related]
38. Strains of Toxoplasma gondii used for tachyzoite antigens to stimulate spleen cells of infected mice in vitro affect cytokine responses of the cells in the culture.
Rodgers L; Wang X; Wen X; Dunford B; Miller R; Suzuki Y
Parasitol Res; 2005 Oct; 97(4):332-5. PubMed ID: 16001280
[TBL] [Abstract][Full Text] [Related]
39. Production and properties of Toxoplasma growth inhibitory factor (Toxo-GIF) and interferon (IFN) in the lymphokines and the circulation of Toxoplasma immune mice.
Sakurai H; Takei Y; Omata Y; Suzuki N
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(1):134-43. PubMed ID: 6173972
[TBL] [Abstract][Full Text] [Related]
40. [Changes of CD4+CD25+ T cells in the spleen of mice infected with Toxoplasma gondii].
Ge YY; Zhang G; Wu JP; Wang Y; Hu W; Tan MJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):189-92. PubMed ID: 18038774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
